Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Brigham & Women's Hospital Multiple Sclerosis Genetic Collection

ABSTRACT: Brigham & Women's Hospital Multiple Sclerosis Genetic Collection

PROVIDER: PRJNA171427 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Brigham and Women's Hospital Multiple Sclerosis Genetic Collection

Project description:The main objective of this GWA study is to identify Multiple Sclerosis (MS) susceptibility loci. Whole-genome association analysis was performed on 924 individuals genotyped on the Affymetrix 6.0 Genechip. The cohort consisted of 860 clinically diagnosed MS patients and 64 control subjects.

| phs000275.v1.p1 | EGA

Homo sapiens

Project description:Brigham & Women's Hospital Multiple Sclerosis Genetic Collection

| PRJNA175696 | ENA

Progressive multiple sclerosis

Project description:Progressive multiple sclerosis

| PRJNA966951 | ENA

Multiple Sclerosis

Project description:Elevated genetic risk for multiple sclerosis originated in Steppe Pastoralist populations

| PRJEB65098 | ENA

Disease phenotype prediction in multiple sclerosis

Project description:Progressive multiple sclerosis (PMS) is currently diagnosed retrospectively. Here, we work towards a set of biomarkers that could assist in early diagnosis of PMS. A selection of cerebrospinal fluid metabolites (n=15) was shown to differentiate between PMS and its preceding phenotype in an independent cohort (AUC=0.93). Complementing the classifier with conformal prediction showed that highly confident predictions could be made, and that three out of eight patients developing PMS within three years of sample collection were predicted as PMS at that time point. Finally, this methodology was applied to PMS patients part of a clinical trial for intrathecal treatment with rituximab. The methodology showed that 68% of the patients decreased their similarity to the PMS phenotype one year after treatment. In conclusion, the inclusion of confidence predictors contributes with more information compared to traditional machine learning, and this information is relevant for disease monitoring. Cohort 1 assays are reported in the current study <a href='https://www.ebi.ac.uk/metabolights/MTBLS1464' rel='noopener noreferrer' target='_blank'>MTBLS1464</a>.Cohort 2 assays are reported in <a href='https://www.ebi.ac.uk/metabolights/MTBLS558' rel='noopener noreferrer' target='_blank'>MTBLS558</a>.

2023-05-31 | MTBLS1464 | MetaboLights

A Case-Controlled Study for genotype-Phenotype Associations in Multiple Sclerosis (Genetic Multiple Sclerosis - GeneMSA)

Project description:A Case-Controlled Study for genotype-Phenotype Associations in Multiple Sclerosis (Genetic Multiple Sclerosis - GeneMSA)

| PRJNA75473 | ENA

Multiple sclerosis and EAE

Project description:Multiple sclerosis and EAE

| PRJNA391342 | ENA

WTCCC case-control study for Multiple Sclerosis

Project description:WTCCC genome-wide case-control association study for Multiple Sclerosis (MS) using the 1958 British Birth Cohort collection as controls.

| EGAS00000000022 | EGA

The Genetic Basis of Progression in Multiple Sclerosis

Project description:The Genetic Basis of Progression in Multiple Sclerosis

| PRJNA839843 | ENA

The Genetic Basis of Progression in Multiple Sclerosis

Project description:The Genetic Basis of Progression in Multiple Sclerosis

| PRJNA839844 | ENA